Fundraising FoxMycoMedica
Shelton, US · 5 known investors
Find your way into MycoMedica
Sign up to see every warm intro you have to MycoMedica
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MycoMedica team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MycoMedica Life Sciences is a biopharmaceutical company developing psilocybin-based treatments for mental health and neurodegenerative disorders. It conducts non-clinical and human clinical studies of low-dose psilocybin, with an initial focus on Premenstrual Dysphoric Disorder and other neuropsychiatric conditions such as OCD, Opioid Use Disorder, and Parkinson's Disease.
Investors · 5
__Twitter.png)
Lauder Partnerslisted by Lauder PartnersLos Altosvia Gary Lauder · inferred
How we know: Lauder Partners's portfolio page · Not right? Tell us
Obvious Ventureslisted by Obvious VenturesSan Francisco · $250K – $6M
How we know: Obvious Ventures's portfolio page · Not right? Tell us
Related companies · 2
CreateCREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Companies working in the same space as MycoMedica.
Frequently asked questions
- What does MycoMedica do?
- MycoMedica Life Sciences is a biopharmaceutical company developing psilocybin-based treatments for mental health and neurodegenerative disorders. It conducts non-clinical and human clinical studies of low-dose psilocybin, with an initial focus on Premenstrual Dysphoric Disorder and other neuropsychiatric conditions such as OCD, Opioid Use Disorder, and Parkinson's Disease.
- Who are MycoMedica's investors?
- MycoMedica's investors include Gaingels, Lauder Partners, Obvious Ventures, Palo Santo VC, True Ventures.
- Where is MycoMedica headquartered?
- MycoMedica is headquartered in Shelton, US.